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T cell exhaustion is common during chronic infec-
tions and can prevent optimal immunity. Although
recent studies have demonstrated the importance
of inhibitory receptors and other pathways in T cell
exhaustion, the underlying transcriptional mecha-
nisms are unknown. Here, we define a role for the
transcription factor Blimp-1 in CD8+ T cell exhaustion
during chronic viral infection. Blimp-1 repressed key
aspects of normal memory CD8+ T cell differentiation
and promoted high expression of inhibitory recep-
tors during chronic infection. These cardinal features
of CD8+ T cell exhaustion were corrected by condi-
tionally deleting Blimp-1. Although high expression
of Blimp-1 fostered aspects of CD8+ T cell exhaus-
tion, haploinsufficiency indicated that moderate
Blimp-1 expression sustained some effector function
during chronic viral infection. Thus, we identify
Blimp-1 as a transcriptional regulator of CD8+ T cell
exhaustion during chronic viral infection and pro-
pose that Blimp-1 acts as a transcriptional rheostat
balancing effector function and T cell exhaustion.
INTRODUCTION
After acute viral infections, antigen-specific CD8+ T cells can
undergo a memory differentiation program that results in the
development and maintenance of robust, functional memory
CD8+ T cells. Once a pathogen is cleared, memory CD8+ T cell
differentiation follows a characteristic differentiation program in
which a subset of IL-7Rahi effector CD8+ T cells persists into
the memory pool, increases expression of IL-7Ra and lymphoid
homing molecules such as CD62L and CCR7, and gains the
ability to produce IL-2 (Kaech and Wherry, 2007; Williams and
Bevan, 2007). These memory CD8+ T cells also acquire several
cardinal properties such as the ability to rapidly respond and re-
activate effector functions upon antigen re-exposure, high prolif-
erative potential, and long-term antigen-independent mainte-
nance via IL-7- and IL-15-driven self-renewal (Kaech and
Wherry, 2007; Williams and Bevan, 2007).
In contrast to acute infections, during chronic viral infections
virus-specific CD8+ T cells undergo an altered pattern of differ-entiation and become exhausted. CD8+ T cell exhaustion is
a transcriptionally altered state of T cell differentiation distinct
from functional effector or memory CD8+ T cells (Wherry et al.,
2007). Although some persisting infections such as Epstein
Barr Virus (EBV) and cytomegalovirus (CMV) induce functional
T cells that control these infections in healthy people, many other
chronic infections in animal models and humans, particularly
those with sustained viral replication, are associated with T cell
exhaustion (Shin and Wherry, 2007). In these situations, ex-
hausted CD8+ T cells undergo a hierarchical loss of function,
ultimately resulting in virus-specific CD8+ T cells with severely
compromised effector function, and in some cases these cells
are physically deleted (Fuller and Zajac, 2003; Wherry et al.,
2003). In addition, unlike normal memory CD8+ T cells generated
after acute infections, during chronic infections virus-specific
CD8+ T cells remain IL-7Ralo, IL-15Rblo, CD62Llo, and IL-2lo (Shin
andWherry, 2007). These virus-specific CD8+ T cells have major
defects in homeostatic proliferation and often become depen-
dent on persisting antigen rather than IL-7 and IL-15 for mainte-
nance (Shin et al., 2007).
Another cardinal feature of exhausted CD8+ T cells is the sus-
tained expression of multiple inhibitory receptors (Blackburn
et al., 2009; Kaufmann et al., 2007; Nakamoto et al., 2008;Wherry
et al., 2007). Whereas the precise role of inhibitory receptors in
the initiation ofCD8+T cell exhaustion remains unclear, consider-
able evidence indicates that the expression of these receptors
is important for regulating multiple functional aspects of CD8+
T cell exhaustion once a chronic infection is established. The pro-
grammed death 1 (PD-1) pathway has received considerable
attention because exhausted CD8+ T cells have substantially
higher expression of this molecule, and blockade of this pathway
in vivo reinvigorates antiviral CD8+ T cell responses (Barber et al.,
2006; Sharpe et al., 2007; Velu et al., 2009). However, additional
pathways, including lymphocyte activation gene 3 (LAG-3), also
have a major role in limiting the effectiveness of exhausted
CD8+ T cells during chronic viral infection (Blackburn et al.,
2009). Other known or potential inhibitory pathways that have
also been associated with T cell dysfunction during chronic viral
infections include 2B4, CD160, PirB, GP49B, CTLA-4, and Tim3
(Blackburn et al., 2009; Jones et al., 2008; Kaufmann et al.,
2007; Nakamoto et al., 2008; Wherry et al., 2007) and different
inhibitory receptors may regulate distinct aspects of functional
exhaustion (Blackburn et al., 2009). Thus, the factors controlling
expression of inhibitory receptors could represent a fundamental
control mechanism for T cell exhaustion.Immunity 31, 309–320, August 21, 2009 ª2009 Elsevier Inc. 309
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Figure 1. Blimp-1 Was Highly Expressed in Exhausted Antigen-Specific CD8+ T Cells during Chronic Viral Infection
(A) Blimp-1message by qRT-PCR. DbGP33+CD8+ T cells were sorted by FACS from LCMVArm (acute)- or clone 13 (chronic)-infectedmice at the indicated d.p.i.
Naive controls were CD44lo CD8+ T cells sorted from Arm immune. Error bars show range of expression in triplicate wells.
(B) Blimp-1 YFP reporter expression in CD8+ T cells on d8 p.i. with LCMV Arm or clone 13. Plots are gated on total CD8+ T cells.
(C) Kinetics of Blimp-1 YFP reporter expression after LCMV Arm or clone 13 infection. Histograms are gated on DbGP33+ CD8+ T cells from the blood of LCMV
Arm (shaded) or LCMV clone 13 (open) infection. Data points in graph show Blimp-1 YFP reporter MFI of DbGP33+ CD8+ T cells from LCMV Arm (black circles) or
LCMV clone 13 (white circles) at the indicated d.p.i. Error bars are standard error of the mean (SEM). n = 2–3 mice per time point.
(D) Blimp-1 YFP reporter MFI in tissues 30 d.p.i. with LCMV Arm or clone 13. Dot plot is gated on total CD8+ T cells. Histograms are gated on DbGP33+ CD8+
T cells from LCMV Arm (shaded) or LCMV clone (open) infection. Open red histograms show CD44lo CD8+ T cells from LCMV Arm infection.Despite recent work on inhibitory receptors and on the tran-
scriptional profiles of exhausted CD8+ T cells (Wherry et al.,
2007), the fundamental transcriptional mechanisms underlying
this type of T cell dysfunction are unknown. In the present
study, we have examined the role of the transcriptional re-
pressor Blimp-1 in CD8+ T cell exhaustion during chronic viral
infection in mice. Blimp-1 is a zinc finger-containing transcrip-
tional repressor perhaps best known for governing fate deci-
sions in memory B cell differentiation. In the germinal center,
expression of Blimp-1 promotes terminal differentiation of
plasma cells and also represses the transcriptional program
of memory B cells (Calame, 2006; Shaffer et al., 2002; Sha-
piro-Shelef et al., 2003). Blimp-1 also has been shown to regu-
late fate decisions and cellular differentiation in other hemato-
poietic and nonhematopoietic cells (John and Garrett-Sinha,
2008). Here, we show that Blimp-1 has an important role as
a transcriptional regulator of CD8+ T cell exhaustion. Elevated
expression of Blimp-1 in virus-specific exhausted CD8+
T cells during chronic viral infection was associated with re-
pression of memory T cell differentiation and elevated expres-
sion of inhibitory receptors. Both of these features of CD8+
T cell exhaustion were reversed when Blimp-1 was condition-
ally deleted. However, haploinsufficient mice controlled chronic
viral infection better than either WT or full conditionally deficient
mice. Thus, our studies indicate that Blimp-1 is a transcriptional
regulator of CD8+ T cell exhaustion and suggest a model in
which Blimp-1 is a transcriptional rheostat regulating the
balance between CD8+ T cell effector function when moder-
ately expressed and CD8+ T cell exhaustion when highly ex-
pressed.310 Immunity 31, 309–320, August 21, 2009 ª2009 Elsevier Inc.RESULTS
Blimp-1 Is Overexpressed in Virus-Specific CD8+ T Cells
during Chronic Viral Infection
To investigate the role of Blimp-1 in CD8+ T cells during chronic
viral infection, we used lymphocytic choriomeningitis virus
(LCMV). LCMV infection of adult mice is a well-established
model with which to examine virus-specific T cell differentiation
during acute versus chronic infection. Infection with the Arm-
strong strain of LCMV (Arm) results in an acute infection with
clearance of infectious virus by day 8–10 postinfection (p.i.)
and generation of functional effector andmemory T cells (Wherry
et al., 2003). In contrast, infection with the clone 13 strain of
LCMV results in a chronic infection with viremia for 2–3 months,
long-term viral persistence in some tissues and T cell exhaustion
(Ahmed et al., 1984; Wherry et al., 2003). To determine the
kinetics of Blimp-1 expression in virus-specific CD8+ T cells
during acute versus chronic LCMV infection, we first used quan-
titative RT-PCR (qRT-PCR) (Figure 1A). DbGP33-specific CD8+
T cells were sorted from the spleens of Arm or clone 13 infected
mice on day 8, 15, and 30 p.i. and Blimp-1 mRNA expression
was examined (Figure 1A). At day 8 p.i., Blimp-1 expression
was upregulated to a similar degree in DbGP33-specific CD8+
T cells from either Arm- or clone 13-infected mice (Figure 1A).
After the first week of infection, Blimp-1 mRNA decreased
modestly in DbGP33-specific CD8+ T cells from LCMV Arm in-
fected mice. In contrast, Blimp-1 was highly upregulated in
virus-specific CD8+ T cells from clone 13 infected mice by day
15 p.i. and remained highly expressed for at least 1 month
(Figure 1A).
Immunity
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examined during acute versus chronic LCMV infection with
a Blimp-1 YFP reporter mouse. After infection with either Arm
or clone 13, YFP expression in the reporter mice was elevated
in CD44hi CD8+ T cells, but remained low in naive (CD44lo)
CD8+ T cells (Figure 1B). DbGP33-tetramer+ CD8+ T cells were
almost uniformly YFP+ (i.e., Blimp-1+) at day 8 p.i. (Figure 1B)
and the MFI of YFP was similar in DbGP33-specific CD8+
T cells between acute and chronic viral infection (Figure 1C).
However, after day 8 p.i., YFP MFI increased in DbGP33-
specific CD8+ T cells during chronic LCMV infection, but
decreased after day 8 subsequent to acute infection
(Figure 1C). Blimp-1-driven YFP expression was not limited to
a specific tissue microenvironment and was elevated in
antigen-specific CD8+ T cells in both lymphoid and nonlymphoid
tissues during chronic viral infection (Figure 1D). There were also
differences in Blimp-1 YFP expression in different epitope-
specific CD8+ T cell populations during chronic infections.
DbNP396-specific CD8+ T cells undergo exhaustion early during
chronic infection and are often physically deleted (Fuller and Za-
jac, 2003; Wherry et al., 2003). These DbNP396-specific CD8+
T cells expressed higher Blimp-1 YFP than the DbGP33-specific
CD8+ T cells that also become exhausted but persist during
chronic infection (Figure S1 available online). Thus, Blimp-1
expression was substantially higher in antigen-specific CD8+
T cells during chronic viral infection than after acute viral infec-
tion. Moreover, the pattern of Blimp-1 expression suggested
a correlation between Blimp-1 expression and T cell dysfunction
and/or terminal differentiation.
Conditional Deletion of Blimp-1 in Activated CD8 T Cells
with Granzyme B-Cre
Blimp-1 has recently been described to play a role in T cell acti-
vation and homeostasis (Kallies et al., 2006; Martins et al., 2006).
On the basis of the substantial increase in Blimp-1 expression
during chronic viral infection, we questioned whether Blimp-1
might have a particular relevance during CD8+ T cell exhaustion.
To examine this issue, we used conditional deletion of Prdm1,
the gene encoding Blimp-1. To avoid any potential complica-
tions due to the action of Blimp-1 in the early events of T cell acti-
vation, we crossed Prdm1fl/flmice (Shapiro-Shelef et al., 2003) to
mice with cre recombinase expression driven by the human
granzyme B promoter (gzmB-cre) (Jacob and Baltimore, 1999).
Hereafter, we refer to these Prdm1fl/fl 3 gzmB-cre mice as
gzmB-cre Prdm1fl/fl. To determine when gzmB-cre was active
after infection, we crossed the gzmB-cre mice to Rosa26-f-
stop-f-YFP mice, which have a floxed stop site upstream of
the gene encoding YFP in the Rosa26 locus. Granzyme B is ex-
pressed in activated CD8+ T cells 1–2 days after activation
(Chang et al., 2007) and accordingly, YFP fluorescence was
present in activated CD25+ CD8+ T cells by 3 days after LCMV
clone 13 infection of gzmB-cre 3 Rosa26-f-stop-f-YFP mice
(Figure 2A). By day 6 p.i., YFP was expressed by the majority
of activated, CD44hi and tetramer+ CD8+ T cells, indicating
cre-mediated recombination had occurred in most responding
CD8+ T cells at this time (Figure 2A, data not shown), although
in the gzmB-cre Prdm1fl/fl mice, it remains possible that some
Blimp-1 mRNA and/or protein could persist temporarily after
gene deletion.Blimp-1 Deficiency Alters Virus-Specific CD8+ T Cell
Differentiation during Chronic Viral Infection
GzmB-crePrdm1fl/fl andwild-type (WT) littermates were infected
with LCMV clone 13, and viral control and T cell responses were
examined. Through the first 20–30 days of infection, the viral
load in the serum and tissues was similar between WT and
gzmB-cre Prdm1fl/fl mice (Figure 2B). The frequency of antigen-
specific CD8+ T cells in the blood was also similar between the
gzmB-cre Prdm1fl/fl and WT groups, although the contraction
phase appeared delayed in the gzmB-cre Prdm1fl/fl mice
(Figure 2C). Spleens of gzmB-cre Prdm1fl/fl mice tended to
contain higher absolute numbers of CD8+ T cells specific for
three different LCMV epitopes compared to WT mice at day
30 p.i. (Figure 2C). There were also more DbGP33-specific
CD8+ T cells in the inguinal lymph nodes of the gzmB-cre
Prdm1fl/flmice, but similar numbers in the bone marrow and liver
of gzmB-cre Prdm1fl/fl and WT mice (Figure 2C). Among the
different virus-specific CD8+ T cell populations examined, we
observed a larger increase in the number DbNP396-specific
CD8+ T cells in the gzmB-cre Prdm1fl/fl mice over WT mice
(3-fold) compared to DbGP33 or DbGP276-specific CD8+ T cell
populations (2.2-fold and 1.8-fold, respectively), suggesting
that deletion of Blimp-1 had the greatest impact on the accumu-
lation of the most severely exhausted CD8+ T cells (Figure 2C).
The phenotype of conditionally Blimp-1-deficient antigen-
specific CD8+ T cells was distinct from WT antigen-specific
CD8+ T cells. Many of the gzmB-cre Prdm1fl/fl antigen-specific
CD8+ T cells expressed CD127 and CD62L, twomolecules asso-
ciated with memory CD8+ T cell differentiation after acute infec-
tions that are not normally expressed by exhausted CD8+ T cells
(Figure 2D). Even DbNP396-specific CD8+ T cells expressed
CD127 and CD62L in the absence of Blimp-1 (Figure S2A).
Despite the expression of some memory-like markers by condi-
tionally Blimp-1-deficient CD8+ T cells, the gzmB-cre Prdm1fl/fl
CD8+ T cells had only modest changes in cytokine production.
IFN-g production was similar between gzmB-cre Prdm1fl/fl and
WT CD8+ T cells and MIP-1a was slightly reduced in the
gzmB-cre Prdm1fl/fl CD8+ T cells (Figure 2E). Although produc-
tion of TNF was slightly elevated in the conditionally Blimp-1-
deficient T cells, both DbGP33-specific and DbNP396-specific
CD8+ T cells from the gzmB-cre Prdm1fl/flmice were still consid-
erably less functional than memory CD8+ T cells from immune
mice, in which 80%–95% of the antigen-specific CD8+ T cells
coproduced IFN-g and TNF (Figure 2E and Figure S2) (Wherry
et al., 2003). In agreement with previous reports (Martins et al.,
2008; Martins et al., 2006), IL-2 production was elevated in the
gzmB-cre Prdm1fl/fl antigen-specific CD8+ T cells to a degree
that was comparable to memory CD8+ T cells after acute viral
infection (Figure 2E and Figure S2). Thus, loss of Blimp-1 in
antigen-specific CD8+ T cells with gzmB-cre did not alter the
initial viral load during chronic infection nor did it substantially
improve effector cytokine production. Conditional deletion of
Blimp-1 did, however, resulted in a trend toward increased
numbers of antigen-specific CD8+ T cells, restored some key
aspects of normal memory CD8+ T cell differentiation, including
CD127 and CD62L expression, and led to the partial restoration
of antigen-specific CD8+ T cell populations that were otherwise
terminally differentiated and deleted during chronic viral infection
(e.g., DbNP396).Immunity 31, 309–320, August 21, 2009 ª2009 Elsevier Inc. 311
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Figure 2. CD8+ T Cell Responses in Blimp-1 Conditional Knockout Mice during Chronic Viral Infection
(A) Efficiency of granzyme B-cre-mediated gene deletion. Rosa26-f-stop-f-YFP x gzmB-cre mice or WT littermates were infected with LCMV clone 13. CD8+
T cells were analyzed for YFP expression at day 3 (blood) and day 6 (spleen) p.i. Plots are gated on total CD8+ T cells and histograms are gated on DbGP33+
CD8+ T cells. Numbers above gates in the histograms indicate the percentage of DbGP33+ CD8+ T cells that are YFP+.
(B) Viral loads in multiple tissues in WT and gzmB-cre Prdm1fl/flmice (CKO). GzmB-cre Prdm1fl/flmice andWT littermates were infected with LCMV clone 13 and
analyzed at day 30 p.i. unless otherwise noted. Viral titers were measured by plaque assay at the indicated time points in the serum and tissues. Data are repre-
sentative of four independent experiments. Error bars in serum titers represent SEM. n = 3–10 mice per time point.
(C) Absolute number of antigen-specific CD8+ T cells in WT and gzmB-cre Prdm1fl/flmice. The frequency of DbGP33+ CD8+ T cells was measured in the blood at
indicated time points. The absolute number of tetramer+ CD8+ T cells wasmeasured in each tissue at day 30 p.i. Numbers above spleen graph indicate the differ-
ence in number between gzmB-cre Prdm1fl/fl andWT for each tetramer+ population. Error bars represent SEM, and n = 4–8 for each tissue. Data represent three
independent experiments.
(D) Phenotype of WT and gzmB-cre Prdm1fl/fl antigen-specific CD8+ T cells. Plots are gated on total CD8+ T cells in the spleen. Numbers in left-hand plots show
percentage of total CD8+ T cells that are DbGP33+. Numbers in the center and right-hand plots indicate the percentage of DbGP33+CD8+ T cells that are positive
for each marker. Graphs represent two independent experiments; ‘‘Arm’’ indicates marker expression for memory CD8+ T cells from Arm immune mice (day
30 p.i.). Error bars are SEM. For CD127, *p = 0.04, **p = 0.002 by Student’s t test.
(E) Effector function of WT and gzmB-cre Prdm1fl/fl antigen-specific CD8+ T cells compared to memory CD8+ T cells (day 30+ Arm immune). Splenocytes were
stimulated with GP33 peptide for 5 hr. Plots are gated on CD8+ T cells. Numbers in each plot show the percent of IFNg producing CD8+ T cells that also produced
the second indicated cytokine. Numbers are graphed to the right. All error bars represent SEM.312 Immunity 31, 309–320, August 21, 2009 ª2009 Elsevier Inc.
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Figure 3. Blimp-1 Expression Correlated with Expression of Inhibitory Receptors on Antigen-Specific CD8+ T Cells during Chronic Viral
Infection
(A) Blimp-1 mRNA in PD-1hi and PD-1int subsets of exhausted CD8+ T cells. Plot is gated onWT CD8+ T cells from spleen at day 30 after LCMV clone 13 infection.
For qPCR, PD-1hi and PD-1int DbGP33+CD8+ T cells were sorted from the spleens of LCMV clone 13-infectedWTmice. Graph shows increase in Blimp-1 expres-
sion over naive CD44lo CD8+ T cells sorted from LCMV Arm immune mice. Error bars show range of expression in triplicate wells.
(B) Blimp-1 YFP reporter expression in inhibitory receptor hi versus lo subsets of exhausted CD8+ T cells. Blimp-1 YFP reporter mice were infected with LCMV
clone 13 and YFP expression was analyzed in the spleen at 30 days p.i. Histograms are gated on DbGP33+ CD8+ T cells that are inhibitory receptorlo (shaded) or
inhibitory receptorhi (open). Numbers in gray show YFP MFI of shaded histograms, numbers in black represent YFP MFI of open histograms.
(C) Correlation of Blimp-1 expression and number of inhibitory markers expressed. Blimp-1 YFP reporter mice were infected with LCMV clone 13, and inhibitory
receptor expression was determined onDbGP33+CD8+ T cells from the spleen at day 30 p.i. Boolean gating established the populations that expressed a combi-
nation of three, two, one, or no inhibitory markers and Blimp-1 YFP MFI was determined for each subgroup. Graph represents two independent experiments. All
error bars represent SEM.
(D) Inhibitory receptor expression on antigen-specific CD8+ T cells fromWT and gzmB-cre Prdm1fl/flmice. GzmB-cre Prdm1fl/fl andWT littermates were infected
with LCMV clone 13 and analyzed on day 30 p.i. for inhibitory marker expression in the spleen. Plots are gated on total CD8+ T cells. Histograms are gated on
DbGP33+ CD8+ T cells. Numbers above the gates indicate the percentage of DbGP33+ CD8+ T cells in each gate. Numbers in red are theMFI of eachmarker. Pie
charts represent DbGP33+CD8+ T cell populations fromWT and gzmB-crePrdm1fl/flmice. Each colored slice indicates the fraction of DbGP33+CD8+ T cells that
expresses a combination of four, three, two, one, or no inhibitory receptors.
(E) Inhibitory receptor expression in total CD44hi CD8+ T cells in WT and gzmB-cre Prdm1fl/flmice 30 days p.i. Histograms are gated on CD44hi CD8+ T cells from
WT (shaded) or gzmB-cre Prdm1fl/fl (open) mice. Open red histograms represent CD44lo CD8+ T cells from WT mice.Conditional Blimp-1 Deletion Reduces Expression
of Inhibitory Receptors
We next examined whether there was any relationship between
the expression of inhibitory receptors and Blimp-1 during
chronic LCMV infection. We have previously found that two sub-
sets of exhausted CD8+ T cells can be identified during chronic
LCMV infection. One subset expresses intermediate amounts
of PD-1 (PD-1int) and is capable of ‘‘revival’’ upon PD-1 pathway
blockade, whereas the other expresses high amounts of PD-1
(PD-1hi) and is more terminally differentiated (Blackburn et al.,
2008); similar observations have been made during HCV infec-
tion in humans (Nakamoto et al., 2008). We sorted virus-specificexhausted PD-1int and PD-1hi CD8+ T cell subsets from chroni-
cally infected mice and assessed Blimp-1 mRNA expression
by qRT-PCR (Figure 3A). The PD-1hi subset had 2- to 3-fold
greater amounts of Blimp-1 mRNA than the PD-1int subset, sug-
gesting a potential role for Blimp-1 in the regulation of PD-1
expression, CD8+ T cell exhaustion, and/or terminal differentia-
tion (Figure 3A).
To examine the relationship between Blimp-1 and inhibitory
receptor expression in more detail, we infected Blimp-1 YFP
mice with LCMV clone 13 and on day 30 p.i., we examined
DbGP33 tetramer+ CD8+ T cells. Blimp-1-driven YFP expression
in DbGP33+ CD8+ T cells correlated with PD-1 expression inImmunity 31, 309–320, August 21, 2009 ª2009 Elsevier Inc. 313
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(Figure S3). Next, we gated on exhausted DbGP33+ CD8+
T cells that expressed high versus intermediate or low expres-
sion of PD-1, LAG-3, 2B4, or CD160 (Figure 3B). The inhibitory
receptorhi subsets consistently had a higher Blimp-1 YFP MFI
than the inhibitory receptorint/lo subsets regardless of which
inhibitory receptor was examined (Figure 3B). This difference
was greatest for 2B4, with a 7.8-fold difference in Blimp-1 YFP
MFI in 2B4hi versus 2B4lo exhausted CD8+ T cells. There was
also a robust difference in Blimp-1 YFP expression in PD-1hi
versus PD-1lo (3.3-fold), LAG-3hi versus LAG-3lo (3.3-fold), and
CD160hi versus CD160lo (1.6-fold). Furthermore, using multipa-
rameter flow cytometry to examine coexpression of three inhib-
itory receptors (PD-1, 2B4, and LAG-3), we found that higher
Blimp-1 expression corresponded to an increase in the number
of inhibitory receptors coexpressed by the same cell (Figure 3C).
Given the correlation between Blimp-1 YFP expression and
inhibitory receptor upregulation, we next examined inhibitory
receptor expression in Blimp-1-conditional-deficient mice
during chronic LCMV infection. On day 30 p.i., DbGP33-specific
CD8+ T cells from gzmB-cre Prdm1fl/flmice expressed consider-
ably less PD-1 and LAG-3 and little CD160 or 2B4 compared to
DbGP33+ CD8+ T cells from WT mice (Figure 3D). DbNP396-
specific CD8+ T cells also exhibited a decrease in PD-1 expres-
sion in gzmB-cre Prdm1fl/fl mice as compared to WT mice
(Figure S2C). In addition, although nearly half of the DbGP33-
specific CD8+ T cells from WT mice coexpressed all four inhibi-
tory receptors, only a small fraction of conditionally Blimp-1-
deficient CD8+ T cells expressed all four of these molecules
simultaneously and more than half of the gzmB-cre Prdm1fl/fl
cells expressed zero or only one inhibitory receptor (Figure 3D).
This difference in expression of multiple inhibitory receptors in
the gzmB-cre Prdm1fl/fl mice was not restricted to the DbGP33-
specific CD8+ T cell population. The overall population of CD44hi
CD8+ T cells from chronically infected WT mice, which con-
tains other LCMV-specific CD8+ T cell populations, had higher
expression of PD-1, LAG-3, 2B4, and CD160 compared to
CD44hi CD8+ T cells from Blimp-1-conditional-deficient mice
(Figure 3D). Together, these data suggest an important role for
Blimp-1 in regulating the elevated expression and coexpression
pattern of inhibitory receptors on exhausted CD8+ T cells.
Conditional Heterozygous Mice Control Infection More
Rapidly than Wild-Type or gzmB-cre Prdm1fl/fl Mice
The decrease in inhibitory receptor expression might be ex-
pected to improve viral control in the gzmB-cre Prdm1fl/fl mice.
However, Blimp-1 is known to regulate expression of granzyme
B (Gong and Malek, 2007) and is involved in generating termi-
nally differentiated (but functional) effector CD8+ cells after acute
infection (Rutishauser et al., 2009; Kallies et al., 2009 [both in this
issue of Immunity]). Whereas the WT mice controlled viremia by
day 60 p.i., gzmB-cre Prdm1fl/fl mice continued to have high
viral titers in the serum 2 months p.i. despite reduced inhibitory
receptor expression (Figure 4A). In addition to WT and gzmB-
cre Prdm1fl/fl mice, we also infected mice with only one intact
copy of the Blimp-1 gene (Prdm1fl/+ 3 gzmB-cre; conditional
heterozygous mice). Conditional haploinsufficiency resulted in
mice that controlled viremia more rapidly than gzmB-cre
Prdm1fl/fl mice (Figure 4A). Unexpectedly, these conditional314 Immunity 31, 309–320, August 21, 2009 ª2009 Elsevier Inc.heterozygous mice also controlled viremia more quickly than
the WT mice and had a lower viral load in some tissues than
either gzmB-cre Prdm1fl/fl or WT mice (Figure 4A). We next
tested whether deletion of only one copy of Prdm1was sufficient
to impact expression of inhibitory receptors. Indeed, these
conditional heterozygous mice, like the gzmB-cre Prdm1fl/fl
mice, had significantly lower MFI of PD-1 compared to virus-
specific CD8+ T cells from theWTmice at day 15 p.i., a time point
when viral load was similar in all three sets of mice (Figures 4B
and 4C). Thus, although mice completely deficient in Blimp-1
had poor long-term viral control compared to WT mice, condi-
tional heterozygous mice had lower PD-1 expression and
controlled chronic infection more rapidly than WT mice.
Conditional Blimp-1 Haploinsufficiency Leads to Better
Cytotoxicity than Full Conditional Deficiency
We next examined the functional properties of virus-specific
CD8+ T cells from WT, conditional heterozygous, and gzmB-
cre Prdm1fl/fl mice. The ability of antigen-specific CD8+ T cells
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Figure 4. Blimp-1 Haploinsufficiency in Antigen-Specific CD8+
T Cells Leads to Rapid Viral Control
(A) Viral titers in gzmB-cre Prdm1fl/fl, conditional heterozygous (het), and WT
littermates day 60 after LCMV clone 13 infection. Viral load was determined
in the serum on the indicated days and in the tissues on day 60 p.i. by plaque
assay. Lines on the graphs represent limit of detection. Viral titers are repre-
sentative of three independent experiments, n = 3–17. For kidney titers, WT
versus conditional heterozygous, *p = 0.03; WT versus gzmB-cre Prdm1fl/fl,
**p = 0.003; conditional heterozygous versus CKO, **p = 0.002 by Student’s
t test. All error bars represent SEM.
(B) PD-1 expression on antigen-specific CD8+ T cells from gzmB-crePrdm1fl/fl,
conditional heterozygous, and WT mice. PD-1 MFI was measured on
DbGP33+ CD8+ T cells from the blood at day 15 p.i. Data are representative
of three experiments. WT versus conditional heterozygous, **p = 0.007; WT
versus gzmB-cre Prdm1fl/fl, *p = 0.01 by Student’s t test.
(C) Representative plots of PD-1 expression at day 15 p.i. in gzmB-cre
Prdm1fl/fl, conditional heterozygous, and WT mice. Plots are gated on total
CD8+ T cells from the blood. Numbers in red indicate the PD-1 MFI of the
DbGP33+ CD8+ T cells. Numbers in black are the percent PD-1+ of the
tetramer+ cells.
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Figure 5. Blimp-1 Regulates Cytoxicity in Antigen-Specific CD8+ T Cells during Chronic Viral Infection
GzmB-cre Prdm1fl/fl, conditional heterozygous, and WT littermates were infected with LCMV clone 13 and analyzed at day 30 p.i. unless otherwise noted.
(A) Function of CD8+ T cells from gzmB-cre Prdm1fl/fl, conditional heterozygous, and WT mice. Splenocytes were stimulated with GP33 peptide for 5 hr and the
percentage of GP33-specific IFN-g+ CD8+ T cells that also produced the second indicated cytokine was determined by ICS. Data are representative of two inde-
pendent experiments, n = 4–6. Error bars are SEM.
(B) Splenocytes from WT, conditional heterozygous, and gzmB-cre Prdm1fl/fl mice were stimulated for 5 hr with GP33 peptide, and degranulation based on
CD107 staining was determined. Plots are gated on total CD8+ T cells. Numbers in plots indicate MFI of IFN-g. Graph shows the number of DbGP33+ CD8+
T cells that are also CD107+. Data represent two independent experiments. Error bars are SEM.
(C) Granzyme B expression in CD8+ T cells from gzmB-cre Prdm1fl/fl, conditional heterozygous, or WT mice. Dot plots are gated on total CD8+ T cells from the
spleen, and histograms are gated on DbGP33+ CD8+ T cells. Numbers above the gates indicate the percentage of DbGP33+ CD8+ T cells that express
granzyme B.
(D) Specific killing by CD8+ T cells from gzmB-cre Prdm1fl/fl, heterozygous, and WT mice as determined by an in vitro killing assay on day 8 and day 30 p.i. with
LCMV clone 13. Equal numbers of DbGP33+ CD8+ T cells were plated with GP33-peptide-labeled target cells at a 2:1 ratio. After 16–20 hr, specific lysis was
calculated. Error bars are SEM.from the conditional heterozygous mice to coproduce IFN-g and
TNF was not dramatically different from WT or gzmB-cre
Prdm1fl/fl cells, although the MFI of IFN-g was higher in WT and
conditional heterozygous CD8+ T cells compared to gzmB-cre
Prdm1fl/fl cells (Figures 5A and 5B). Coproduction of IFN-g and
MIP-1a was slightly increased in conditional heterozygous
compared to gzmB-cre Prdm1fl/fl CD8+ T cells, but conditional
heterozygous and WT CD8+ T cells were similar in this regard
(Figure 5A). IL-2 production was high only in the gzmB-cre
Prdm1fl/fl mice, suggesting that even one copy of Prdm1 was
sufficient to repress IL-2 during chronic infection (Figure 5A).
Thus, production of antiviral cytokines by exhausted CD8+
T cells was similar regardless of the number of copies of Prdm1.
Blimp-1 expression could be particularly relevant for cytotoxic
activity given that Blimp-1 has been implicated in the expression
of granzyme B (Gong and Malek, 2007). Virus-specific CD8+
T cells from WT, conditional heterozygous, and gzmB-cre
Prdm1fl/fl mice were equally capable of degranulating on the ba-
sis of CD107a surface expression after peptide stimulation (Fig-
ure 5B). However, antigen-specific CD8+ T cells from gzmB-cre
Prdm1fl/flmicewere severely deficient in expression of granzyme
B compared to both conditional heterozygous and WT mice
(Figure 5C). The ability of antigen-specific CD8+ T cells from
conditionally Blimp-1-deficient mice to lyse peptide-coated
targets was also substantially impaired by day 8 p.i. and was
essentially absent by day 30 p.i., although killing was similar byCD8+ T cells from the conditional heterozygous and WT mice
(Figure 5D). Normally, during chronic LCMV infection, cytotox-
icity declines as the infection progresses (Wherry et al., 2003).
Indeed, the degree of killing by WT and gzmB-cre Prdm1fl/fl cells
decreased by day 30, but this residual killing was still higher than
that observed in the complete absence of Blimp-1 (Figure 5D). In
contrast, LCMV Arm immune mice sustain the ability to robustly
reactivate killing activity (Figure S4) (Barber et al., 2003). These
observations suggest that although high expression of Blimp-1
was detrimental to CD8+ T cell responses and was associated
with substantial upregulation of inhibitory receptors, retention
of one intact copy of Prdm1 and likely intermediate expression
of Blimp-1 was required to induce and/or maintain cytotoxic
potential. Thus, conditional Blimp-1 deficiency indicated a key
role for this transcription factor in controlling some aspects of
T cell exhaustion (increased inhibitory receptors, repression of
memory T cell differentiation), but complete loss of Blimp-1
also compromised the low cytotoxic activity found in WT or
conditional Blimp-1 heterozygous CD8+ T cells during chronic
LCMV infection.
The Role of Blimp-1 in CD8+ T Cell Exhaustion Is Cell
Intrinsic
Blimp-1 appears to be a good candidate for transcriptional
control of some aspects of CD8+ T cell exhaustion during chronic
viral infection. The data described above, however, do not ruleImmunity 31, 309–320, August 21, 2009 ª2009 Elsevier Inc. 315
Immunity
Blimp-1 Regulates CD8+ T Cell ExhaustionPD-1 LAG-3 CD160 2B4
A B
C
CKO
WT
IL-2 MIP-1α TNFα
IFN
γ
WT
CKO
0.7 96.6 16.5
2.1 83.0 26.3
GzmB-Cre CD4-Cre
Db
GP
33
Granzyme B
18.0
88.2
CKO
WT
D E
CD8
Ly
5.2
CD44 CD127 CD62L
Db
GP
33
CKO
WT
16.578.6
4.410.2
WT CKO
0
25
50
75
WT CKO0
5
10
15
20
25
PD-1 LAG-3 CD160 2B4
0
1
2
3
4
0
1
2
3
4
** *
Figure 6. The Role of Blimp-1 in CD8+ T Cells during Chronic LCMV Infection Was Cell Intrinsic
(A) Phenotype of CD8+ T cells frommixedBM chimeras. Left-most plot is gated on total CD8+ T cells from the spleen. The top row of plots is gated on Ly5.2+CD8+
T cells (gzmB-crePrdm1fl/fl), and the bottom row is gated on Ly5.2- CD8+ T cells (WT). Numbers in plots indicate the percentage of DbGP33+CD8+ T cells positive
for each marker. Numbers are graphed to the right. Data are representative of two experiments, n = 4. Error bars are SEM. For CD127, **p = 0.005 and for CD62L,
*p = 0.01 by Student’s t test.
(B) Effector function of CD8+ T cells frommixed BM chimeras. Splenocytes were stimulated with GP33 peptide for 5 hr. The top row of plots is gated on gzmB-cre
Prdm1fl/fl, and the bottom row is gated onWTCD8+ T cells. Numbers in plots indicate the percentage of IFN-g+ CD8+ T cells that also produce a second cytokine.
(C) Granzyme B expression in CD8+ T cells from mixed BM chimeras. Plots are gated on CD8+ T cells from the spleen. Histograms are gated on DbGP33+ CD8+
T cells. The top row is gated on gzmB-cre Prdm1fl/fl, and bottom row is gated on WT. Numbers above gates show percentage of DbGP33+ CD8+ T cells that
express granzyme B.
(D) Inhibitory receptor expression on CD8+ T cells frommixed BM chimeras. Histograms are gated onWT DbGP33+ CD8+ T cells (shaded) or gzmB-cre Prdm1fl/fl
DbGP33+CD8+ T cells (open). Pie charts show eitherWT or gzmB-cre Prdm1fl/flDbGP33+CD8+ T cells. Colored slices indicate the fraction of the total population
that expressed a combination of four, three, two, one, or no inhibitory markers.
(E) Inhibitory receptor expression on CD8+ T cells frommixed BM chimeras reconstituted with CD4-cre Prdm1fl/fl andWT bone marrow. Histograms are gated on
WT DbGP33+ CD8+ T cells (shaded) or open CD4-cre Prdm1fl/fl DbGP33+ CD8+ T cells (open). Pie charts show either WT or CD4-cre Prdm1fl/fl DbGP33+ CD8+
T cells.out the possibility that Blimp-1 deficiency in other cell types, or
changes in environmental factors such viral load and/or patho-
genesis of infection, could have an impact on antigen-specific
CD8+ T cells. To examine the cell-intrinsic role of Blimp-1 in
CD8+ T cell exhaustion, we generated mixed bone marrow
(BM) chimeras by injecting equal numbers of T and B cell-
depleted bone marrow cells from Ly5.2+ gzmB-cre Prdm1fl/fl
and Ly5.1+ WT animals into lethally irradiated Ly5.1+ recipient
mice (Figure S5). After reconstitution, the mixed BM chimeras
were infected with LCMV clone 13 and analyzed 4 weeks after
infection (Figure S5).
At 1month after infection, the differentiation state and function
of virus-specific WT and gzmB-cre Prdm1fl/fl CD8+ T cells from
viremic (data not shown) mixed BM chimeras was examined.
As observed in separate WT and gzmB-cre Prdm1fl/fl mice,
a higher proportion of Blimp-1-deficient antigen-specific CD8+
T cells in the mixed chimeras expressed CD127 and CD62L
compared to the WT antigen-specific CD8+ T cells (Figure 6A).
In addition, the functional profiles of WT and gzmB-cre
Prdm1fl/fl cells in the mixed chimeras paralleled observations in
individual WT and gzmB-cre Prdm1fl/fl mice. Production of IL-2
and TNF were elevated, and MIP-1a was slightly decreased in
gzmB-cre Prdm1fl/fl CD8+ T cells compared to WT CD8+ T cells316 Immunity 31, 309–320, August 21, 2009 ª2009 Elsevier Inc.(Figure 6B). In the mixed BM chimeras, the virus-specific
gzmB-cre Prdm1fl/fl cells also had defective granzyme B expres-
sion, whereas the WT cells sustained expression of this protein
(Figure 6C). Finally, gzmB-cre Prdm1fl/fl antigen-specific CD8+
T cells in the mixed BM chimeras expressed lower amounts of
inhibitory receptors compared to WT antigen-specific CD8+
T cells in the same animals (Figure 6D). Although we did not ob-
serve as drastic a difference in LAG-3 expression in the mixed
chimeras as we did in individual mice, PD-1 expression was
decreased in Blimp-1-deficient antigen-specific CD8+ T cells
compared to WT antigen-specific CD8+ T cells in the same
host (Figure 6D). The CD160hi and 2B4hi subsets present in WT
virus-specific CD8+ T cells were also dramatically reduced or
absent from the gzmB-cre Prdm1fl/fl antigen-specific CD8+
T cell populations (Figure 6D). The pattern of coexpression of
multiple inhibitory markers was also clearly distinct for gzmB-
cre Prdm1fl/fl andWTDbGP33-specific CD8+ T cells in the mixed
chimeras. Whereas less than half of the gzmB-cre Prdm1fl/fl
DbGP33-specific CD8+ T cells coexpressed three or more inhib-
itory receptors, nearly two-thirds of the WT cells in the same
mice coexpressed three or more inhibitory receptors (Figure 6D).
In parallel experiments, we also generated mixed chimeras by
using BM from WT and Prdm1fl/fl X CD4-cre mice and observed
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function (data not shown), and expression of inhibitory receptors
(Figure 6E). This difference in inhibitory receptor expression
between the CD4-cre Prdm1fl/fl CD8+ T cells and WT CD8+
Tcellswasapparent inboth theexpression level of individual inhib-
itory markers and the coexpression patterns (Figure 6E). These
observations suggest that the changes observed in the gzmB-
cre Prdm1fl/fl CD8+ T cells were not due to the timing of cre-medi-
ated recombination or deletionofBlimp-1 in granzymeB-express-
ing non-CD8+ T cells. Thus, the mixed BM chimeras indicate that
Blimp-1 has a cell-intrinsic role in regulating inhibitory receptor
expression and identify Blimp-1 as a transcriptional regulator of
CD8+ T cell exhaustion during chronic viral infections.
DISCUSSION
Although several transcription factors have been shown to regu-
late effector and memory T cell differentiation after acute infec-
tions, the transcriptional mechanisms of T cell exhaustion have
been unclear. In this study, we identify a role for the transcrip-
tional repressor Blimp-1 in regulating several defining features
of CD8+ T cell exhaustion during chronic viral infection. Ex-
hausted CD8+ T cells had substantially higher expression of
Blimp-1 than functional effector or memory CD8+ T cells gener-
ated after acute infection. Higher expression of Blimp-1 corre-
lated with upregulated inhibitory receptor expression and re-
pression of memory T cell properties. Conversely, conditional
deletion of Blimp-1 resulted in reduced inhibitory receptor
expression by exhausted CD8+ T cells and demonstrated the
central involvement of Blimp-1 in preventing normal memory
T cell differentiation during chronic viral infection. These studies,
however, also indicated that although high expression of Blimp-1
was associated with key aspects of T cell exhaustion, some
Blimp-1 was essential for sustained T cell function including
cytolysis, which in turn was necessary for eventual control of
chronic infection. Thus, Blimp-1 appears to act as a transcrip-
tional rheostat controlling CD8+ T cell functionality at low
amounts and CD8+ T cell exhaustion when highly expressed.
CD8+ T cell exhaustion is a common feature of many chronic
viral infections in both animal models as well as humans and is
a likely reason for poor pathogen control in these situations
(Shin and Wherry, 2007). For example, T cell dysfunction, in-
cluding expression of inhibitory receptors, occurs not only in
mice but also during infections such as SIV in monkeys and
HIV, HBV, and HCV in humans (Shin and Wherry, 2007). Thus,
there has been considerable interest in the molecular mecha-
nisms of T cell exhaustion. High and sustained expression of
PD-1 has emerged as a hallmark of T cell exhaustion, and block-
ing this pathway can reinvigorate immune responses during per-
sisting infections (Freeman et al., 2006; Sharpe et al., 2007). In
the current study, Blimp-1 expression was two to three times
higher in the more terminally differentiated PD-1hi subset of ex-
hausted CD8+ T cells compared to the PD-1int-lo subset that
can be ‘‘revived’’ by antibody blockade (Blackburn et al., 2008;
Nakamoto et al., 2008). Other inhibitory receptors, including
LAG-3, 2B4, and CD160, are also upregulated by exhausted
CD8+ T cells, and these pathways cooperate to negatively regu-
late CD8+ T cell responses during chronic viral infection (Black-
burn et al., 2009). Blimp-1 also regulated expression of theseadditional inhibitory receptors, given that in the absence of
Blimp-1, the expression of these receptors was lower during
chronic LCMV infection. It should be noted inhibitory receptors
are unlikely to be the only regulatory pathways involved in
T cell exhaustion. Key roles for elevated IL-10 and the loss of
IL-21 have been described (Brooks et al., 2006; Ejrnaes et al.,
2006; Elsaesser et al., 2009; Frohlich et al., 2009; Yi et al.,
2009), and CD8+ T cell exhaustion is associated with dramatic
changes in global gene expression (Wherry et al., 2007). It is
interesting that despite lower expression of inhibitory receptors
in the absence of Blimp-1, these CD8+ T cells remained poor
cytokine producers. It is possible that other negative regulatory
pathways compensate in this setting or that Blimp-1 positively
regulates antiviral cytokine expression. A third possibility is
that Blimp-1 controls one ‘‘module’’ of the transcriptional pro-
gram of T cell exhaustion including inhibitory receptor expres-
sion and memory repression. Although inhibitory receptors are
clearly linked to T cell function, another layer of transcriptional
control that influences expression of antiviral cytokines could
exist. Such an idea of overlapping transcriptional modules is
emerging for Foxp3+ Treg cells (Koch et al., 2009; Zheng et al.,
2009). Future studies are necessary to dissect additional tran-
scriptional pathways associated with T cell exhaustion and
Blimp-1-independent regulation of cytokine production.
After activation during an acute infection, antigen-specific
effector CD8+ T cells can adopt one of two fates: terminally
differentiated effector CD8+ T cells or memory CD8+ T cell
precursors (Chang et al., 2007; Joshi et al., 2007; Sarkar et al.,
2008). The transcription factor Tbet has been implicated in the
development of terminally differentiated effector CD8+ T cells
versus memory precursors (Intlekofer et al., 2007; Joshi et al.,
2007; Sarkar et al., 2008), and other transcription factors such
as Eomesodermin (Intlekofer et al., 2005), Id2 (Cannarile et al.,
2006), Bcl6, and Bcl6b (Ichii et al., 2004; Manders et al., 2005),
and Bmi1 (Heffner and Fearon, 2007) can also regulate memory
CD8+ T cell differentiation after acute infection. During chronic
infection, antigen-specific CD8+ T cells differentiate into a popu-
lation transcriptionally distinct from effector and memory CD8+
T cells present after acute infection (Wherry et al., 2007), but
the transcription factors involved have been unclear. In the
germinal center, Blimp-1 controls the terminal differentiation of
B cells into long-lived plasma cells and also represses the devel-
opment of memory B cells (Calame, 2006) and Blimp-1 has a key
role in determining cell-fate decisions in many settings outside
the immune system (Hayashi et al., 2007; Ohinata et al., 2005;
Horsley et al., 2006; Roy and Ng, 2004; de Souza et al., 1999).
During chronic LCMV infection, CD8+ T cell exhaustion becomes
established progressively after the effector phase and important
events in this progression, such as the appearance of the PD-1hi
subset of exhausted CD8+ T cells (Barber et al., 2006; Wherry
et al., 2007; Blackburn et al., 2008), correspond to the further up-
regulation of Blimp-1 observed 2–4 weeks p.i. In addition,
because mice with one intact copy of the Prdm1 gene were
not intermediate between WT and gzmB-cre Prdm1fl/fl mice
but rather achieved more efficient control of infection than WT
or gzmB-cre Prdm1fl/fl mice, it is likely that the amount of
Blimp-1 has a crucial impact on CD8+ T cell differentiation and
exhaustion during chronic viral infection. It appeared that low
or intermediate expression of Blimp-1 was required for someImmunity 31, 309–320, August 21, 2009 ª2009 Elsevier Inc. 317
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occurred during chronic viral infection promoted CD8+ T cell
exhaustion and repressed memory differentiation. Thus, our
data is consistent with the idea that the considerable upregula-
tion of Blimp-1 in virus-specific CD8+ T cells by 1 month of
chronic viral infection is a developmental switch that promotes
key aspects of CD8+ T cell exhaustion.
Our studies also point to a critical role for sustained cytolytic
potential during chronic viral infections. Recent work has dem-
onstrated the importance of cytotoxicity in long-term control of
chronic infections in humans (Appay et al., 2000; Migueles
et al., 2002; Migueles et al., 2008; Trabattoni et al., 2004).
Although exhausted CD8+ T cells are known to have partial
defects in killing compared to highly functional effector or
memory CD8+ T cells (Wherry et al., 2003), some residual cyto-
toxicity by antigen-specific CD8+ T cells can be maintained
in vivo (Agnellini et al., 2007). Blimp-1 conditional heterozygous
mice controlled virus substantially more quickly than GzmB-cre
Prdm1fl/fl mice, and this difference corresponded to sustained
cytolysis in the conditional heterozygous mice compared to the
GzmB-cre Prdm1fl/fl mice. However, conditional heterozygous
mice also controlled virus in vivo more rapidly than WT mice,
despite similar killing and cytokine production in vitro. It is
possible that lower PD-1 expression by conditional heterozy-
gous mice led to improvements in effector function in vivo that
were not obvious in vitro, as has been observed with blockade
of other inhibitory pathways such as LAG-3 (Blackburn et al.,
2009). Conditional heterozygous mice also had slightly more
virus-specific CD8+ T cells than WT mice. Higher numbers of
virus-specific CD8+ T cells and improved effector functions
in vivo by conditional heterozygous mice could account for this
more efficient control of infection compared to WT mice, but
future studies are necessary to investigate these issues further.
In summary, these studies provide a framework to begin dis-
secting Blimp-1 targets, regulation of Blimp-1 activity, and other
transcriptional pathways involved in T cell dysfunction during
chronic infection. Although clearly additional transcription
factors and pathways contribute to T cell exhaustion, our results
identify Blimp-1 as a transcriptional regulator of CD8+ T cell
exhaustion and repressor of memory CD8+ T cell differentiation
during chronic viral infection.
EXPERIMENTAL PROCEDURES
Animals and Viruses
Four- to six-week-old C57BL/6 or C57BL/6 Ly5.2CR (Ly5.1+) mice were
purchased from NCI. Rosa26-f/stop/f-YFP mice were purchased from Jack-
son Laboratories. BAC transgenic Blimp-1 YFP reporter mice were from
E. Meffre (Yale University, New Haven, CT). Prdm1fl/fl mice were from K. Cal-
ame (Columbia University, New York, NY), granzyme B-cre mice were from
J. Jacob (Emory University, Atlanta, GA), and CD4-cre mice were from
S. Reiner (University of Pennsylvania, Philadelphia, PA). Mouse strains were
crossed and mice were bred, maintained in the Wistar Institute, and used in
accordance with IACUC guidelines. Mice were infected with 2 3 105 plaque-
forming units (PFUs) of LCMV Armstrong (Arm) i.p. or 2 3106 PFU LCMV
clone-13 (Cl-13) i.v. as described (Wherry et al., 2003). Virus was grown and
titered as described (Wherry et al., 2003).
Lymphocyte Isolation and Flow Cytometry
Lymphocyte isolation from lymphoid and nonlymphoid tissues, surface stains,
intracellular cytokine stains (ICS), and CD107 assay were performed as previ-318 Immunity 31, 309–320, August 21, 2009 ª2009 Elsevier Inc.ously described (Barber et al., 2006; Wherry et al., 2003). All antibodies were
purchased fromBiolegend except for CD127, CD160, TNF, IL-2 (eBioscience),
2B4 (eBioscience, BD Biosciences), LAG-3 (AbD Serotec), granzyme B (Cal-
tag), and MIP-1a (R&D Systems). LIVE/DEAD dead-cell stain, CFSE, streptavi-
din-APC, and streptavidin-Quantum dot 655 were purchased from Invitrogen.
MHC class I peptide tetramers were made and used as described previously
(Wherry et al., 2004; Wherry et al., 2003). All flow cytometry data were acquired
on an LSRII (BD Biosciences) and analyzed by FlowJo (Treestar). Pie charts
were created with the Pestle and SPICE programs (Mario Roederer; Vaccine
Research Center, NIAID, NIH).
Bone Marrow Chimeras
Bonemarrow cells from Ly5.1+WT and gzmB-cre Prdm1fl/fl (either Prdm1fl/fl3
gzmB-cre or Prdm1fl/fl3CD4-cre) mice were T and B cell depleted with MACS
magnetic beads (Miltenyi Biotec) and adoptively transferred at a 1:1 ratio into
lethally irradiated (1000 rad) C57BL/6 Ly5.2Cr (Ly5.1+) mice. Mice were fed
antibiotic for 2 weeks and allowed to reconstitute for eight weeks before use.
Quantitative PCR
Cells were sorted on a FACSAria (BD Biosciences). RNA extraction was per-
formed with Trizol (Invitrogen). cDNA was generated using the High Capacity
cDNA Archive Kit (Applied Biosystems). Relative quantification real-time
PCR was performed on an ABI Prism 7000 with primers purchased from
Applied Biosystems. HPRT was used as an endogenous control, and gene
expression measured as increase in expression over naive CD8+ T cells.
In Vitro Killing Assays
CD8+ T cells were purified with MACS magnetic beads (Miltenyi Biotec) from
spleens of gzmB-cre Prdm1f/f, heterozygous, and WT mice in accordance
with the manufacturer’s protocol. Target cells were either labeled with GP33
peptide or SIINFEKL peptide and CFSE labeled at two different concentra-
tions. Equal numbers of DbGP33+ CD8+ T cells were plated at a 2:1 ratio
with the labeled target cells, and total cell numbers were normalized with naive
splenocytes. The cells were incubated at 37C for 16–20 hr and specific lysis
was calculated as described (Hermans et al., 2004).
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